The increased production of NAA in ALS BAT, which is coupled with its impaired intracellular catabolism due to ASPA downregulation, may partially contribute to NAA release during the disease course as a consequence of muscle metabolic reprogramming. Here, ASPA is linked to amyotrophic lateral sclerosis.